Latest Options Issuance News

Whitebark Energy Limited has issued a supplementary bidder's statement updating its $3 million capital raising and correcting share valuation details in its ongoing takeover offer for King Energy Limited.

Adelong Gold Limited has secured an additional $400,000 through a placement, increasing total funds raised to $1.573 million. This capital injection aims to fast-track exploration and development at its flagship gold project and lithium assets in Brazil.

Adelong Gold Limited has raised $1.173 million through a placement to fund exploration and development at its NSW gold project and lithium ventures in Brazil. The capital raise, including free attaching options, signals investor confidence as the company advances towards production.

Simble Solutions Limited has raised $280,000 through a premium-priced equity placement, signaling renewed investor confidence in its sustainability software platforms.

Revolver Resources reports encouraging leach test results at its Dianne Copper Mine, moving closer to production in H2 2025, while securing new funding through a royalty agreement to support development and exploration.

RLG Ltd has successfully raised $900,000 through a two-tranche placement to fund the development of its food and health products and expand global sales channels. The second tranche, involving options issuance, awaits shareholder approval.

Lodestar Minerals has raised $520,000 through a share placement to fund its inaugural reverse circulation drilling at the Darwin gold project in Chile, signaling a pivotal step in its exploration strategy.

Enova Mining has completed a $1.5 million placement to fund key development and exploration activities across its CODA, Charley Creek, and Lithium Valley projects. The capital injection aims to accelerate metallurgical testing and engineering work critical to unlocking the value of these rare earth and critical mineral assets.

BPH Energy Limited's December 2024 quarterly report reveals strategic capital placements and investments in hydrogen and medical technology, alongside ongoing regulatory challenges with the PEP-11 permit.